Potential utility of antineoplaston A-10 levels in breast cancer
- 15 May 2000
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 155 (1), 67-70
- https://doi.org/10.1016/s0304-3835(00)00408-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphyBritish Journal of Cancer, 1999
- c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic valueBreast Cancer Research and Treatment, 1998
- Cancer associated serum antigen (CASA) levels in patients with breast carcinoma and in 3 control groups without breast cancerArchiv für Gynäkologie, 1998
- CEA, MCA, CA 15.3 and CA 549 and their combinations in expressing and monitoring metastatic breast cancer: a prospective comparative studyEuropean Journal Of Cancer, 1995
- CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancerClinica Chimica Acta; International Journal of Clinical Chemistry, 1991
- The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigenCancer, 1991
- Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic diseaseCancer, 1989
- Carcinoembryonic antigen as a monitor of recurrent breast cancerJournal of Surgical Oncology, 1982
- Ein humoraler Faktor in der Genese der essentiellen HypertonieKlinische Wochenschrift, 1971
- Presence of three peptides in urinary kinin (substance Z) preparations*1Life Sciences, 1968